Keros Therapeutics, Inc. SEC filings KROS
Keros Therapeutics, Inc. has 536 filings in SEC EDGAR's recent list, going back to Apr 29, 2016. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 22, 2026 | — |
| DEF 14A | Proxy statement | Apr 22, 2026 | Jun 3, 2026 |
| DEFA14A | Additional proxy material | May 27, 2025 | — |
| DEFA14A | Additional proxy material | May 19, 2025 | — |
| DEFA14A | Additional proxy material | May 19, 2025 | — |
| DEFA14A | Additional proxy material | May 19, 2025 | — |
| DEFA14A | Additional proxy material | May 9, 2025 | — |
| DEFA14A | Additional proxy material | Apr 23, 2025 | — |
| DEF 14A | Proxy statement | Apr 23, 2025 | Jun 4, 2025 |
| DEFA14A | Additional proxy material | Apr 17, 2024 | — |
| DEF 14A | Proxy statement | Apr 17, 2024 | May 30, 2024 |
| DEFA14A | Additional proxy material | Apr 24, 2023 | — |
| DEF 14A | Proxy statement | Apr 24, 2023 | Jun 6, 2023 |
| DEFA14A | Additional proxy material | Apr 18, 2022 | — |
| DEF 14A | Proxy statement | Apr 18, 2022 | Jun 1, 2022 |
| DEFA14A | Additional proxy material | Apr 19, 2021 | — |
| DEF 14A | Proxy statement | Apr 19, 2021 | Jun 1, 2021 |
Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- KROS (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Lexington, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1664710
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.